Medications for management of opioid use disorder

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Jennifer L KoehlPatrick J Bridgeman

Abstract

The use of buprenorphine, methadone, and long-acting naltrexone for treatment of opioid use disorder (OUD) is discussed, including a review of current literature detailing treatment approaches and action steps to optimize treatment in acute care and office-based settings. The U.S. epidemic of opioid-related deaths has been driven by misuse of prescription opioids and, increasingly, illicit drugs such as heroin, fentanyl, and fentanyl analogs, necessitating a refocusing of treatment efforts on expanding access to life-saving, evidence-based OUD pharmacotherapy. Inpatient treatment of opioid withdrawal includes acute symptom control through a combination of nonopioid medications and long-term pharmacotherapy to lessen opioid craving and facilitate stabilization and recovery. Methadone and buprenorphine reduce opioid craving, increase treatment retention, reduce illicit opioid use, and increase overall survival. Buprenorphine has logistical advantages over methadone, such as greater flexibility of treatment setting and less risk of adverse effects. Studies have shown the efficacy of long-acting injectable naltrexone to be comparable to that of buprenorphine if patients are detoxified prior to initiation of therapy; however, patien...Continue Reading

References

Jan 1, 1987·The American Journal of Drug and Alcohol Abuse·L HandelsmanP D Kanof
Dec 1, 1993·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·G C Harris, G Aston-Jones
Aug 20, 2003·Journal of Psychoactive Drugs·Donald R Wesson, Walter Ling
Mar 23, 2005·The American Journal of Cardiology·Bridget A MartellMarc N Gourevitch
Jun 22, 2005·Clinical Pharmacokinetics·Alexander Elkader, Beth Sproule
Oct 20, 2005·Pharmacotherapy·Mori J KrantzJulia H Arnsten
Feb 28, 2006·Alcoholism, Clinical and Experimental Research·Joi L DunbarKenneth C Lasseter
Mar 12, 2008·Acta Anaesthesiologica Scandinavica·O M S FredheimO Dale
Nov 6, 2013·Journal of Addiction Medicine·Louis E BaxterBonnie B Wilford
Mar 13, 2014·Annals of Family Medicine·Eliza HutchinsonRoger A Rosenblatt
Jan 6, 2015·British Journal of Clinical Pharmacology·Stéphane MoulyFlorence Vorspan
Jan 15, 2015·Annals of Family Medicine·Roger A RosenblattEric H Larson
Apr 29, 2015·JAMA : the Journal of the American Medical Association·Gail D'OnofrioDavid A Fiellin
Jun 23, 2015·Journal of Pain & Palliative Care Pharmacotherapy· U S Department Of Health And Human Services
Aug 25, 2015·Journal of Substance Abuse Treatment·Michael S GordonBernard Silverman
Sep 8, 2015·Journal of Pain and Symptom Management·James H FloryNatalie Moryl
May 10, 2016·The Cochrane Database of Systematic Reviews·Suzanne NielsenNicholas Lintzeris
Nov 20, 2016·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Stefan G Kertesz
May 31, 2017·Journal of Substance Abuse Treatment·Andrew S Huhn, Kelly E Dunn
Feb 6, 2018·Addiction·Brantley P JarvisKenneth Silverman
Mar 22, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Roxanne SaucierNabarun Dasgupta
Oct 17, 2018·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Helen Valenstein-MahAdam J Gordon
Nov 1, 2018·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Michael S ToceEdward W Boyer
Jan 4, 2019·MMWR. Morbidity and Mortality Weekly Report·Lawrence SchollGrant Baldwin

❮ Previous
Next ❯

Citations

Aug 11, 2020·Drugs·Reda M Chalhoub, Peter W Kalivas
Sep 18, 2020·Current Opinion in Nephrology and Hypertension·Payel J RoyUNKNOWN HOPE Consortium
Apr 9, 2020·Bioelectronic Medicine·Imran S QureshiAndrew C H Chen
Mar 31, 2021·Experimental Neurology·Tao WangShuanglin Hao
Jun 3, 2021·International Journal of Environmental Research and Public Health·Morgane Guillou-LandreatCaroline Victorri-Vigneau
May 25, 2021·The Mental Health Clinician·Aimee N JensenCeleste N Nadal
Jun 26, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jongyeon KimBryan Lau
Aug 20, 2021·Experimental Neurology·Shuanglin Hao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Psychiatry Reports
Anjalee SharmaRobert P Schwartz
Expert Opinion on Pharmacotherapy
Daniel AyangaThomas R Kosten
© 2021 Meta ULC. All rights reserved